Occam Sciences
2011
FOUNDED
PRIVATE
STATUS
Seed
LATEST DEAL TYPE
$300K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Provider of therapeutic drug development services intended to provide bio-available forms of approved drugs. The company's services includes developing of drugs using green chemistry to design drugs that are more bioavailable, enabling researchers to develop oral drugs.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 33 Whitney Street
- New Haven, CT 06510
- United States
+1 (203) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Occam Sciences’s full profile, request a free trial.
Occam Sciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 21-Oct-2011 | $300K | 00000 | Completed | Startup |
Occam Sciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Elm Street Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Warner Babcock Institute for Green Chemistry | Other | Minority | 000 0000 | 000000 0 |
Occam Sciences Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Robert Bettigole | Chief Executive Officer, President, Treasurer & Chairman |
Occam Sciences Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Brian Dixon | Occam Sciences | Board Member | 000 0000 | |
| David Whittaker MD | Elm Street Ventures | Board Member | 000 0000 | |
| John Warner | Occam Sciences | Board Member | 000 0000 | |
| Joseph Pont | Occam Sciences | Board Member | 000 0000 | |
| Robert Bettigole | Self | Chief Executive Officer, President, Treasurer & Chairman | 000 0000 |